Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 150

Results For "science"

1737 News Found

ValGenesis selected for validating French pharma firm
Digitisation | February 18, 2022

ValGenesis selected for validating French pharma firm

With ValGenesis VLMS, change control driven validation activities are reduced from weeks to mere hours, and the company gains faster access to detailed metrics that help reduce costs and cycle time


Top five pharma looks to LifeSphere IDMP for regulatory readiness
News | February 18, 2022

Top five pharma looks to LifeSphere IDMP for regulatory readiness

ArisGlobal's industry-leading regulatory software chosen by top pharmaceutical company for IDMP preparation and global readiness


Modis and ValGenesis partner to bring Best-in-Class validation processes to Italian pharma
Digitisation | February 18, 2022

Modis and ValGenesis partner to bring Best-in-Class validation processes to Italian pharma

The partnership will help digitize and automate existing tasks traditionally managed on paper, significantly reducing costs and lead times while increasing compliance


Ribon Therapeutics appoints Prakash Raman as President and CEO
People | February 18, 2022

Ribon Therapeutics appoints Prakash Raman as President and CEO

Dr. Raman has succeeded Victoria Richon


Agilent acquires Virtual Control’s AI technology to enhance lab productivity
Digitisation | February 18, 2022

Agilent acquires Virtual Control’s AI technology to enhance lab productivity

Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis


Ligand posts strong 2021 performance
News | February 18, 2022

Ligand posts strong 2021 performance

Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.


AptarGroup reported 2021 sales at US $3.23 billion
News | February 18, 2022

AptarGroup reported 2021 sales at US $3.23 billion

AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.


Rajiv Gupta to retire as chairman of Avantor
News | February 17, 2022

Rajiv Gupta to retire as chairman of Avantor

Gupta to retire at the end of his current term on May 12, 2022, after more than a decade of service, during which time Avantor has transformed into a global life sciences leader


Jubilant Ingrevia commissions Diketene derivatives facility
Biotech | February 17, 2022

Jubilant Ingrevia commissions Diketene derivatives facility

The commissioned facility has a capacity of 7,000 TPA to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate, and Ter-Butyl Acetoacetate)


Swissmedic  approves BeiGene's Brukinsa
Drug Approval | February 17, 2022

Swissmedic approves BeiGene's Brukinsa

With this approval, Brukinsa is now approved in 44 markets as BeiGene continues to advance its global registration, including the EU, US, and Great Britain